简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-06-05 10:08 OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
2024-06-04 10:16 Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo
2024-06-04 10:08 Merck’s Innovative Oncology Pipeline of DNA Damage Response Inhibitors and Antibody-Drug Conjugates Poised to Advance Cancer Treatment
2024-06-04 10:03 Germans Trias i Pujol Hospital in Spain Launches Telehealth and Remote Patient Management Program Using Masimo W1® Medical Watches and Radius VSM™ Wearable Continuous Vital Signs Monitors
2024-06-03 13:00 Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
2024-06-03 09:55 Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
2024-06-03 09:51 Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2024-05-31 16:31 Morinaga Milk’s New Research Breakthrough Backed the Superiority of its Human-Residential Bifidobacteria (HRB) Strains in Metabolizing Toxin Precursor in the Gut
2024-05-31 15:18 Quit Like Sweden Urges Progressive Tobacco Control to Save Millions of Lives on World No Tobacco Day
2024-05-31 11:00 Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing
2024-05-31 10:00 Rhea Launches with Senior Advisory Panel, Growth Acquisitions and Strategic Partnerships to Advance Fertility Journeys for the Modern Family
2024-05-30 10:25 Asymchem Welcomes Franck Mevellec as Senior Director, Business Development
2024-05-30 10:00 We Are Innovation and Anglo-American University Hosted the Exclusive Premiere of "How Sweden Quit Smoking"
2024-05-30 09:47 JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
2024-05-29 22:43 Bio-Sourcing and Partners Launch €3.4M EU Project in Inflammatory Indications with €1.9M EUREKA Eurostars Subsidies
2024-05-29 10:26 Kolmar BNH Expands Its Global Market by Launching HemoHIM G in Taiwan
2024-05-29 10:12 TVM Capital Healthcare Announces the Closing of its Saudi Arabia-Focused TVM Healthcare Afiyah Fund
2024-05-28 10:59 Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial
2024-05-27 10:45 European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
2024-05-24 15:47 Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe

Business Wire Weibo

Press Releases

Latest Releases